CRISPR Therapeutics AG (NASDAQ:CRSP) is among the top 10 stocks to buy from Cathie Wood’s stock portfolio. CRISPR made up ...

HIV treatment has entered a revolutionary new era, one where a single yearly injection can keep the virus undetectable, and ...

KOL panel to discuss how vispa-cel, an anti-CD19 allogeneic CAR-T cell therapy, can broaden access for patients with second-line large B cell lymphoma including through use in the community setting ...

So, even via the more modest predictions, people will be able to double their longevity. When you reach 100 years old, you ...

A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

If approved, Regeneron and Tessera's TSRA-196 could become the first curative therapy to reach patients with AATD, who have ...

Georgia students broke into the world spotlight after showcasing early Lyme detection advances that could save patients years of suffering.

Research projects to enhance mineral exploration, improve disease resistance in canola, boost respiration efficiency in ...

According to The New England Journal of Medicine, investigators at Uppsala University Hospital implanted a product called ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a series of notable trades on Monday, December 1, according to ...